GlassScriptPhysician profile
Wanda P Adefris
NPI 1235115577
$409.02
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $41.96 · 2021: $153 · 2022: $32.38 · 2023: $81.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $80.53 | 2021 | |
| Ethicon US, LLC | $52.59 | 2019-2023 | Surgicel Nu-Knit, Enseal |
| Smith+Nephew, INC. | $41.13 | 2020-2021 | |
| Daiichi Sankyo INC. | $39.80 | 2019-2022 | |
| Hologic Sales and Service, LLC | $38.06 | 2020-2021 | |
| Abbvie INC. | $28.93 | 2019-2023 | Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $27.49 | 2019-2023 | |
| Roche Diagnostics Corporation | $22.49 | 2019 | |
| Dysis Medical, INC. | $20.62 | 2021 | |
| Exeltis, USA INC. | $17.41 | 2023 | Slynd |
| Novo Nordisk INC | $16.98 | 2023 | Wegovy |
| Therapeuticsmd, INC. | $15.02 | 2019 | |
| Organon LLC | $7.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Adefris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.